TEACHERS ADVISORS, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$258,000
+32.3%
55,7500.0%0.00%
Q4 2018$195,000
-82.7%
55,750
-50.0%
0.00%
-100.0%
Q3 2018$1,124,000
+176.2%
111,500
+98.3%
0.00%0.0%
Q2 2018$407,000
+49.6%
56,217
+24.9%
0.00%
Q1 2018$272,000
-37.2%
45,0160.0%0.00%
-100.0%
Q4 2017$433,000
+8.2%
45,0160.0%0.00%0.0%
Q3 2017$400,000
-29.7%
45,0160.0%0.00%0.0%
Q2 2017$569,000
+24.8%
45,016
+3.7%
0.00%0.0%
Q1 2017$456,000
+38.2%
43,412
+20.9%
0.00%0.0%
Q4 2016$330,000
-22.0%
35,9010.0%0.00%0.0%
Q3 2016$423,000
-9.0%
35,9010.0%0.00%0.0%
Q2 2016$465,000
-19.0%
35,9010.0%0.00%0.0%
Q1 2016$574,000
-94.0%
35,901
-89.2%
0.00%
-94.4%
Q4 2015$9,560,000
-1.1%
333,927
-1.6%
0.02%
-5.3%
Q3 2015$9,662,000
-45.9%
339,502
-31.7%
0.02%
-42.4%
Q2 2015$17,868,000
-10.6%
497,437
+44.7%
0.03%
-10.8%
Q1 2015$19,984,000
+3275.7%
343,787
+2348.5%
0.04%
+3600.0%
Q4 2014$592,000
-89.5%
14,041
-90.3%
0.00%
-90.9%
Q3 2014$5,626,000
-6.9%
145,065
-25.0%
0.01%
-8.3%
Q2 2014$6,042,000
-16.1%
193,465
+11.2%
0.01%
-25.0%
Q1 2014$7,205,000
+70.6%
173,912
+59.4%
0.02%
+60.0%
Q4 2013$4,223,000
+1609.7%
109,091
+1448.5%
0.01%
+900.0%
Q3 2013$247,000
+194.0%
7,045
+16.0%
0.00%
Q2 2013$84,0006,0740.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
HealthInvest Partners AB 788,175$10,199,0004.68%
SCOPIA CAPITAL MANAGEMENT LP 8,987,313$116,296,0002.40%
Antipodean Advisors LLC 305,294$3,951,0002.39%
Freshford Capital Management, LLC 475,984$6,159,0001.81%
Folger Hill Asset Management LP 1,597,945$20,677,0001.61%
JW Asset Management, LLC 150,638$1,949,0001.55%
12 West Capital Management LP 623,791$8,072,0001.30%
Orbimed Advisors 4,688,240$60,666,0000.63%
CYPRESS FUNDS LLC 135,584$1,754,0000.41%
Rock Springs Capital Management LP 365,500$4,730,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders